Entries by Viro Research
Efficacy of the SHINGRIX Vaccine for Preventing Shingles, by Sex, Geographic Region, and Ancestry
INTRODUCTION: Surprisingly, much of the general public do not know one of the human Herpesviruses, varicellazoster virus (VZV), causes chickenpox, and results in a life-long infection. VZV can re-activate after decades of being dormant in sensory nerve ganglia (usually in those over 60 years of age) to cause shingles infection.
Does Herpes Zoster Increase the Risk of Stroke and Myocardial Infarction
INTRODUCTION: Herpes zoster (HZ) reactivation is characterized as a vascular rash of unilateral distribution that can also cause complications such as post-herpetic neuralgia, ophthalmic zoster, and other neurological diseases. Emerging epidemiological and clinical data recognizes an association between HZ and subsequent acute strokes and myocardial infarction (MI).
Increased Risk of Herpes Zoster (HZ) with Immune-Mediated Diseases
INTRODUCTION: Patients have a higher risk of HZ with diseases such as rheumatoid arthritis (RA), psoriasis (PsO), and inflammatory bowel-related diseases (IBD) such as ulcerative colitis (UC) and Crohn’s disease (CD). Using immunosuppressive therapy, which treats these diseases, increases the risk of HZ. DISCUSSION: The most common risk factor for HZ is increasing age, presumably […]
Using Lateral Flow Assays to Detect Herpes Viruses in Saliva
INTRODUCTION: Oral fluids have been used to detect Herpes virus antibodies, including secretory IgA, IgM, and IgG. Herpes virus particles have also been identified in saliva. Several Herpes viruses, such as Epstein–Barr virus (EBV), varicella-zoster virus (VZV), and herpes-simplex-1 (HSV-1), have even been detected in the saliva of Astronauts from shuttle-flights and ISS missions . […]
Inventor of SHINGRIX Develops New Chickenpox and Shingles Virus Detection Test
Abbas Vafai, Ph.D. inventor of shingles vaccine, SHINGRIX, develops ZosterGent® VZV Identification Reagent, a more sensitive test in detecting the shingles virus. SNELLVILLE, Ga., June 9, 2020 (Newswire.com) – Viro Research, developer of high quality biologics and reagents, announced today the launch of ZosterGent® for lesion testing of at-risk patients suspected of having chickenpox or […]
A Lateral Flow Assay for Detecting IgG/IgM for COVID-19
INTRODUCTION: Numerous labs are developing antibody assays to detect COVID-19. There are presently (as of May 1, 2020) four FDA approved assays for detecting IgG/IgM and three for detecting IgG only. Four of these assays use a lateral flow assay (LFA) architecture. All of the assays use the viral S1 glycoprotein as the antibody target. […]